Imaging of the Thyroid and Parathyroid Glands

Surgical Clinics of North America

Volumn 91, Issue 1, 2011, Pages 15-32

  Vazquez, Bianca J ^a   Richards, Melanie L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hyperparathyroidism; Parathyroid imaging; Thyroid imaging; Thyroid nodule; Thyroid ultrasound

Indexed keywords

ANTITHYROID AGENT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; SODIUM IODIDE I 123; SODIUM IODIDE I 131; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201; THYROTROPIN;

CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLICULAR CARCINOMA; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOCYTOMA; PARATHYROID ADENOMA; PARATHYROID GLAND; POSITRON EMISSION TOMOGRAPHY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER; THYROID GLAND; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID SURGERY;

ADENOMA; HUMANS; MAGNETIC RESONANCE IMAGING; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78650260368     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2010.10.015     Document Type: Review

References (60)

1. Sakorafas G.H. Historical evolution of thyroid surgery: from the ancient times to the dawn of the 21st century. World J Surg 2010, (8):1793-1804.
2. Becker W.F. Pioneers in thyroid surgery. Ann Surg 1977, 185:493-504.
3. Dean D.S., Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008, 22(6):901-911.
4. Wang C., Crapo L.M. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997, 26:189-218.
5. Papini E., Guglielmi R., Bianchini A., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002, 87(5):1941-1946.
6. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
7. Frates M.C., Benson C.B., Doubilet P.M., et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006, 91(9):3411-3417.
8. Hopkins C.R., Reading C.C. Thyroid and parathyroid imaging. Semin Ultrasound CT MR 1995, 16(4):279-295.
9. Sheth S. Role of ultrasonography in thyroid disease. Otolaryngol Clin North Am 2010, 43(2):239-255.
10. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19:1167-1214.
11. Danese D., Sciacchitano S., Farsetti A., et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998, 8:15-21.
12. Lew J.I., Rodgers S.E., Solorzano C.C. Developments in the use of ultrasound for thyroid cancer. Curr Opin Oncol 2010, 22(1):11-16.
13. Mendez W., Rodgers S.E., Lew J.I., et al. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules. Ann Surg Oncol 2008, 15:2487-2492.
14. Jabiev A.A., Ikeda M.H., Reis I.M., et al. Surgeon performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Ann Surg Oncol 2009, 16(11):3140-3145.
15. Ahuja A., Chick W., King W., et al. Clinical significance of the comet-tail artifact in thyroid ultrasound. J Clin Ultrasound 1996, 24(3):129-133.
16. Bonavita J.A., Mayo J., Babb J., et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone?. AJR Am J Roentgenol 2009, 193(1):207-213.
17. Jeh S.K., Jung S.L., Kim B.S., et al. Evaluating the degree of conformity of papillary carcinoma and follicular carcinoma to the reported ultrasonographic findings of malignant thyroid tumor. Korean J Radiol 2007, 8:192-197.
18. Sillery J.C., Reading C.C., Charboneau J.W., et al. Thyroid follicular carcinoma: sonographic features of 50 cases. AJR Am J Roentgenol 2010, 194(1):44-54.
19. Stulak J.M., Grant C.S., Farley D.R., et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006, 141(5):489-494.
20. Gharib H., Papini E., Paschke R., et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2010, 16(Suppl 1):1-43.
21. Rago T., Santini F., Scutari M., et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007, 92(8):2917-2922.
22. Wang Y., Dan H.J., Dan H.Y., et al. Differential diagnosis of small single solid thyroid nodules using real-time ultrasound elastography. J Int Med Res 2010, 38(2):466-472.
23. Smith J.R., Oates E. Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls. Clin Nucl Med 2004, 29(3):181-193.
24. Price D.C. Radioisotopic evaluation of the thyroid and parathyroids. Radiol Clin North Am 1993, 31:991-1015.
25. Leger A.F., Pellan M., Dagousset F., et al. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments. Br J Radiol 2005, 78:428-432.
26. Morris L.F., Waxman A.D., Braunstein G.D. The nonimpact of thyroid stunning: remnant ablation rates in 131I scanned and nonscanned individuals. J Clin Endocrinol Metab 2001, 86:3507-3511.
27. Wong K.T., Choi F.P., Lee Y.Y., et al. Current role of radionuclide imaging in differentiated thyroid cancer. Cancer Imaging 2008, 10(8):159-162.
28. Fatourechi V., Hay I.D., Mullan B.P., et al. Are post-therapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?. Thyroid 2000, 10:573-577.
29. Shapiro B., Vittoria R., Ayman J., et al. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 2000, 30:115-132.
30. Shie P., Cardarelli R., Sprawls K., et al. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2009, 30(9):742-748.
31. Bogsrud T.V., Karantanis D., Nathan M.A., et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun 2007, 28:373-381.
32. Are C., Hsu J.F., Ghossein R.A., et al. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol 2007, 14:3210-3215.
33. Grant C.S., Thompson G.B., Farley D.R., et al. The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma. World J Surg 2008, 32(5):708-715.
34. Kirsch E., Hammer B., von Arx G. Graves' orbitopathy: current imaging procedures. Swiss Med Wkly 2009, 139(43-44):618-623.
35. Reading C.C., Gorman C.A. Thyroid imaging techniques. Clin Lab Med 1993, 13(3):711-724.
36. Weber A.L., Randolph G., Aksoy F.G. The thyroid and parathyroid glands. CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am 2000, 38(5):1105-1129.
37. Jeong H.S., Baek C.H., Son Y.I., et al. Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT. Clin Endocrinol (Oxf) 2006, 65(3):402-407.
38. Chen L., Luo Q., Shen Y., et al. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med 2008, 49(12):1952-1957.
39. Gotway M.B., Higgins C.B. MR imaging of the thyroid and parathyroid glands. Magn Reson Imaging Clin N Am 2000, 8(1):163-182.
40. Mihailović J., Stefanović L.J., Prvulovic M. Magnetic resonance imaging in diagnostic algorithm of solitary cold thyroid nodules. J BUON 2006, 11(3):341-346.
41. Johnson N.A., Tublin M.E., Ogilvie J.B. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol 2007, 188(6):1706-1715.
42. Smith J.R., Oates M.E. Radionuclide imaging of the parathyroid glands: patterns, pearls, and pitfalls. Radiographics 2004, 24(4):1101-1115.
43. Lorberboym M., Minski I., Macadziob S., et al. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med 2003, 44(6):904-908.
44. Carlier T., Oudoux A., Mirallié E., et al. 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur J Nucl Med Mol Imaging 2008, 35(3):637-643.
45. Ruda J.M., Hollenbeak C.S., Stack B.C. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005, 132(3):359-372.
46. Civelek A.C., Ozalp E., Donovan P., et al. Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 2002, 131(2):149-157.
47. Pham T.H., Sterioff S., Mullan B.P., et al. Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism. World J Surg 2006, 30(3):327-332.
48. Hindié E., Ugur O., Fuster D., et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009, 36(7):1201-1216.
49. Richards M.L., Thompson G.B., Farley D.R., et al. Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg 2008, 196(6):937-942.
50. American Institute of Ultrasound in Medicine AIUM practice guideline for the performance of a thyroid and parathyroid ultrasound examination. J Ultrasound Med 2003, 22:1126-1130.
51. Solorzano C.C., Carneiro-Pla D.M., Irvin G.L. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg 2006, 202(1):18-24.
52. Richards M.L., Grant C.S. Current applications of the intraoperative parathyroid hormone assay in parathyroid surgery. Am Surg 2007, 73(4):311-317.
53. Thompson G.B., Grant C.S., Perrier N.D., et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg 1999, 134(7):699-704.
54. Ernst O. Hyperparathyroidism: CT and MR findings. J Radiol 2009, 90(3 Pt 2):409-412.
55. Patel C.N., Salahudeen H.M., Lansdown M., et al. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol 2010, 65(4):278-287.
56. Tublin M.E., Pryma D.A., Yim J.H., et al. Localization of parathyroid adenomas by sonography and technetium Tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?. J Ultrasound Med 2009, 28(2):183-190.
57. Mortenson M.M., Evans D.B., Lee J.E., et al. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg 2008, 206(5):888-895.
58. Rodgers S.E., Hunter G.J., Hamberg L.M., et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 2006, 140(6):932-940.
59. Gotway M.B., Reddy G.P., Webb W.R., et al. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology 2001, 218(3):783-790.
60. Kang Y.S., Rosen K., Clark O.H., et al. Localization of abnormal parathyroid glands of the mediastinum with MR imaging. Radiology 1993, 189(1):137-141.